NO20004281L - 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament - Google Patents

6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament

Info

Publication number
NO20004281L
NO20004281L NO20004281A NO20004281A NO20004281L NO 20004281 L NO20004281 L NO 20004281L NO 20004281 A NO20004281 A NO 20004281A NO 20004281 A NO20004281 A NO 20004281A NO 20004281 L NO20004281 L NO 20004281L
Authority
NO
Norway
Prior art keywords
present
provides
group
alkyl
formula
Prior art date
Application number
NO20004281A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004281D0 (no
Inventor
Jennifer Ann Dumont
Alan Joseph Bitonti
David Roger Borcherding
Harry Randall Munson
Patrick Wai-Kwok Shum
Norton Paul Peet
Original Assignee
Aventis Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Holdings Inc filed Critical Aventis Holdings Inc
Publication of NO20004281D0 publication Critical patent/NO20004281D0/no
Publication of NO20004281L publication Critical patent/NO20004281L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20004281A 1998-02-26 2000-08-25 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament NO20004281L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26
PCT/US1999/003451 WO1999043676A2 (en) 1998-02-26 1999-02-18 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines

Publications (2)

Publication Number Publication Date
NO20004281D0 NO20004281D0 (no) 2000-08-25
NO20004281L true NO20004281L (no) 2000-10-18

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004281A NO20004281L (no) 1998-02-26 2000-08-25 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament

Country Status (31)

Country Link
EP (1) EP1056745B1 (et)
JP (1) JP2002504553A (et)
KR (1) KR100568658B1 (et)
CN (1) CN1128149C (et)
AP (1) AP1258A (et)
AR (1) AR019822A1 (et)
AT (1) ATE269332T1 (et)
AU (1) AU748178B2 (et)
BR (1) BR9908325A (et)
CA (1) CA2320448C (et)
CZ (1) CZ291604B6 (et)
DE (1) DE69918062T2 (et)
DK (1) DK1056745T3 (et)
EE (1) EE04315B1 (et)
ES (1) ES2219038T3 (et)
HK (1) HK1030948A1 (et)
HU (1) HUP0100931A3 (et)
IL (2) IL138044A0 (et)
NO (1) NO20004281L (et)
NZ (1) NZ506234A (et)
OA (1) OA11480A (et)
PL (1) PL344021A1 (et)
PT (1) PT1056745E (et)
RU (1) RU2191777C2 (et)
SI (1) SI1056745T1 (et)
SK (1) SK12912000A3 (et)
TR (1) TR200002482T2 (et)
TW (1) TW541308B (et)
UA (1) UA62996C2 (et)
WO (1) WO1999043676A2 (et)
ZA (1) ZA991548B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
US6627633B2 (en) * 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
ATE322494T1 (de) * 2000-01-07 2006-04-15 Universitaire Instelling Antwe Purin derivate, ihre herstellung und verwendung
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
MXPA02010222A (es) 2000-04-18 2003-05-23 Agouron Pharma Pirazoles para inhibir proteina cinasa.
EP1307462A2 (en) 2000-08-09 2003-05-07 Agouron Pharmaceuticals, Inc. Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
WO2002016326A1 (en) 2000-08-18 2002-02-28 Agouron Pharmaceuticals, Inc. Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
DK1377579T3 (da) * 2000-10-31 2009-08-31 Aventis Pharma Inc Acyl- og sulfonylderivater af 6,9-disubstitueret-2(trans-1,4-diaminocyklohexyl)puriner og deres anvendelse som antiproliferative midler
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
GB2378180B8 (en) * 2001-06-27 2009-10-21 Cyclacel Ltd New purine derivatives
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
WO2004069233A1 (ja) * 2003-02-04 2004-08-19 Kabushiki Kaisha Yakult Honsha 乳癌耐性蛋白阻害剤
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
AU2007235524B2 (en) * 2006-03-30 2013-09-12 Ptc Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
MY150993A (en) * 2007-10-05 2014-03-31 Verastem Inc Pyrimidine substituted purine derivatives
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
WO2013130461A1 (en) 2012-02-29 2013-09-06 The Scripps Research Institute Wee1 degradation inhibitors
EP3020829B1 (en) * 2013-07-12 2021-11-17 Kyoto University Pharmaceutical composition capable of inhibiting abnormal splicing causative of onset or progress of a genetic disease
BR112017015019A2 (pt) 2015-01-16 2018-01-30 The General Hospital Corporation compostos para melhorar a splicing de mrna
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
US20220251085A1 (en) * 2019-07-21 2022-08-11 University Of Virginia Patent Foundation Cysteine binding compositions and methods of use thereof
WO2024105159A1 (en) * 2022-11-16 2024-05-23 University Of Zurich Ligands of the m6a-rna readers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
CA2234609C (en) * 1995-11-01 2006-11-28 Novartis Ag 2-amino-6-anilino-purine derivatives and processes for their preparation
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
NO20004281D0 (no) 2000-08-25
OA11480A (en) 2004-05-05
DE69918062D1 (de) 2004-07-22
DK1056745T3 (da) 2004-10-25
WO1999043676A3 (en) 1999-10-21
ZA991548B (en) 1999-08-26
TW541308B (en) 2003-07-11
CA2320448C (en) 2005-02-01
BR9908325A (pt) 2000-11-07
EE04315B1 (et) 2004-06-15
CN1291983A (zh) 2001-04-18
EE200000501A (et) 2002-02-15
KR20010041315A (ko) 2001-05-15
EP1056745A2 (en) 2000-12-06
ES2219038T3 (es) 2004-11-16
IL138044A (en) 2006-04-10
SI1056745T1 (en) 2004-12-31
HUP0100931A3 (en) 2002-08-28
CN1128149C (zh) 2003-11-19
CZ20003106A3 (cs) 2000-12-13
IL138044A0 (en) 2001-10-31
JP2002504553A (ja) 2002-02-12
CA2320448A1 (en) 1999-09-02
DE69918062T2 (de) 2005-06-02
EP1056745B1 (en) 2004-06-16
NZ506234A (en) 2003-05-30
PT1056745E (pt) 2004-09-30
AU748178B2 (en) 2002-05-30
TR200002482T2 (tr) 2002-10-21
CZ291604B6 (cs) 2003-04-16
HUP0100931A2 (hu) 2002-04-29
RU2191777C2 (ru) 2002-10-27
PL344021A1 (en) 2001-09-24
WO1999043676A2 (en) 1999-09-02
HK1030948A1 (en) 2001-05-25
SK12912000A3 (sk) 2001-08-06
AP1258A (en) 2004-03-15
AR019822A1 (es) 2002-03-20
KR100568658B1 (ko) 2006-04-07
AP2000001923A0 (en) 2000-09-30
UA62996C2 (en) 2004-01-15
AU3299099A (en) 1999-09-15
ATE269332T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
NO20004281L (no) 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament
CA2320474A1 (en) 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines
NO20020391L (no) 8-Fenyl-6,9-dihydro-[1,2,4]-triazolo [3,4-i]-purin-5-on- derivater
DK1406876T3 (da) 2-anilinopyrimidinderivater som inhibitorer af cyclinafhængige kinaser
NO20045099L (no) Peptid-derivater omfattende tiazepingruppen for behandling av hyperlipidemiske tilstander
NO20061700L (no) 2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
NO20063931L (no) Nye sammensetninger inneholdende kinolinforbindelser
NO20044599L (no) 3-amino-tieno[2,3-b]pyridin-2-karboksysyreamid-forbindelser og fremgangsmater for fremstilling og anvendelser av dem
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
NO20053133L (no) Kjemiske forbindelser.
NO20043851L (no) Derivater av 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidin med CDK inhibitorisk aktivitet
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
NO20004089L (no) Nye triazolo(4,5-d)pyrimidinforbindelser
JPH0317080A (ja) 置換ピリドピリミジン誘導体
UY25519A1 (es) Procedimiento para preparar antagonista del receptor de vitronectina
NO160297C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
NO20026081L (no) Nye forbindelser
NO982072L (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
NO992731D0 (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
NO20013601L (no) Nye morfolinobenzamidsalter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application